Biotic specialist ProBiotix Health has launched two new precision probiotic formulations for menopause and post-menopausal health, YourBiotixMH and YourBiotixPMH.
The women's health probiotic formulations are designed to support a user's cardiovascular wellness; an important consideration in this demographic due to the high prevalence of heart and vascular disease within it.
"Research tells us that post-menopausal women have a five times higher risk of heart attack, while raised cholesterol affects up to 77% of women between the ages of 45 and 64," stated CEO of ProBiotix, Steen Andersen.
"This is primarily due to the decline in oestrogen that occurs during menopause, which significantly increases the risk of elevated LDL (bad) cholesterol levels, while reducing HDL (good) cholesterol levels, increasing blood pressure and contributing to arterial stiffness and atherosclerosis.”
With estimates suggesting that up to 1.1 billion women worldwide will be transitioning through menopause by the end of 2025, ProBiotix wanted to create an alternative to hormonal based therapies that don't come with unwanted side effects.
From this idea, the company created YourBiotixMH and YourBiotixPMH. The probiotic-based formulations contain:
- ProBiotix Health's LPLDL: A clinically backed precision probiotic that can support cardiovascular health, with studies revealing that the nutraceutical could reduced total cholesterol by up to 37%, LDL by 36%, decreased Apolipoprotein B by 28%, increased HDL by 5%, and reduced blood pressure by 5%
- Soy isoflavones: A Plant-based bioactive and natural phytoestrogen that can mitigate the impacts of hormonal decline
- Thiamine: A nutrient that contributes to the normal functioning of the heart and energy-yielding metabolism necessary for cardiovascular health
- Vitamin B6: To support mood, hormonal balance, energy levels and psychological function
- Vitamin D: To support bone health, as bone density often decreases during/after the menopause
YourBiotixMH is designed to address key health challenges associated with hormonal changes, as well as energy metabolism and cardiovascular health.
Slightly different in formulation, YourBiotixPMH was created to target issues that emerge once oestrogen levels have declined — placing a specific focus on post-menopausal cognition, bone strength and cardiovascular health.
“We believe that a science-led approach is crucial in developing preventative health measures, and our precision probiotic has robust scientific validation to back its efficacy,"
"By addressing cardiometabolic health through precision probiotics, we can meet the consumer desire to extend healthspan as life expectancy goes up," Andersen concluded.
Both YourBiotixMH and YourBiotixPMH will be launching at Vitafoods Europe 2025.